NEW MEDICINES LISTED ON THE PBS

Media Releases

Australians suffering from melanoma and multiple sclerosis have new treatment options, with new and amended PBS listings. 🔸 Tafinlar® (dabrafenib) and Mekinist® (trametinib) will be extended to include subsidy for post-surgery treatment for patients who have Stages IIIB, IIIC and IIID melanoma. 🔸 Gilenya® (fingolimod) will be amended to include a new strength of this medicine for…

$27 million for new PBS medicines

Media Releases

The Government will invest $27 million to provide affordable access to three new medicines through the Pharmaceutical Benefits Scheme (PBS), helping Australians living with complications following stroke, fighting cancer, and experiencing syphilis in northern, central and southern Australia. The September 1 PBS listings will include amending the current listing for Opdivo® (Nivolumab) for the treatment…